Smoking status by DCCT treatment group at baseline and at the end of an average of 6.5 years of follow-up.</p
Rates of biochemically verified 7-day point prevalence smoking abstinence by intervention group (int...
Most patients with substance use disorders are also heavy tobacco smokers, which imply an important ...
<p>Data are presented for the entire study population and also grouped according to the Fagerström T...
<p>Smoking status after twelve months of follow-up, by smoking status at baseline.</p
(A) Never (stars), former (pluses), and current (black circles) smokers. (B) Never (stars) and ever ...
<p>Smoking and ENDS use at one year follow-up for baseline dual users (Smoker + ENDS user) (N = 248)...
Verified continuous smoking abstinence and 7-day point prevalence (intention-to-treat) by group.</p
<p>Patient data before and 1 year after successful smoking cessation in the lesser (A) and greater (...
<p>Meta-regression of follow-up period on relative risk, smoking cessation (follow-up >six months).<...
Summary of Key Findings •Smoking abstinence at end of program: –Intent to treat analysis: 32.2%(83/2...
Smoking abstinence rates and mean daily cigarette consumption were observed in 1326 participants in ...
Daily number of smoked cigarettes before, during, after three days of stimulation, and after 4 month...
WOS: 000367541400006Smoking is still the most important cause of preventable diseases and premature ...
*<p><i>P</i><0.05,</p>**<p><i>P</i><0.01 vs. before smoking cessation therapy.</p>†<p>Two-way repeat...
This study examined the utility and accuracy of collateral reports of smoking status among 256 absti...
Rates of biochemically verified 7-day point prevalence smoking abstinence by intervention group (int...
Most patients with substance use disorders are also heavy tobacco smokers, which imply an important ...
<p>Data are presented for the entire study population and also grouped according to the Fagerström T...
<p>Smoking status after twelve months of follow-up, by smoking status at baseline.</p
(A) Never (stars), former (pluses), and current (black circles) smokers. (B) Never (stars) and ever ...
<p>Smoking and ENDS use at one year follow-up for baseline dual users (Smoker + ENDS user) (N = 248)...
Verified continuous smoking abstinence and 7-day point prevalence (intention-to-treat) by group.</p
<p>Patient data before and 1 year after successful smoking cessation in the lesser (A) and greater (...
<p>Meta-regression of follow-up period on relative risk, smoking cessation (follow-up >six months).<...
Summary of Key Findings •Smoking abstinence at end of program: –Intent to treat analysis: 32.2%(83/2...
Smoking abstinence rates and mean daily cigarette consumption were observed in 1326 participants in ...
Daily number of smoked cigarettes before, during, after three days of stimulation, and after 4 month...
WOS: 000367541400006Smoking is still the most important cause of preventable diseases and premature ...
*<p><i>P</i><0.05,</p>**<p><i>P</i><0.01 vs. before smoking cessation therapy.</p>†<p>Two-way repeat...
This study examined the utility and accuracy of collateral reports of smoking status among 256 absti...
Rates of biochemically verified 7-day point prevalence smoking abstinence by intervention group (int...
Most patients with substance use disorders are also heavy tobacco smokers, which imply an important ...
<p>Data are presented for the entire study population and also grouped according to the Fagerström T...
DOI
Add to ORKG